A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASC47 in Healthy and Obese Subjects

NCT06427590 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Weight Management

Interventions

DRUG: ASC47
DRUG: Matching placebo

Sponsor

Ascletis Pharma (China) Co., Limited